Physician profile
Surender Singh
NPI 1376534339
$2,668.49
in general payments reported to CMS, 2019-2025
21 companies · $26.72 in 2025
The $26.72 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $486 · 2021: $417 · 2022: $606 · 2023: $417 · 2024: $36.94 · 2025: $26.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $705.82 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $389.10 | 2019-2023 | Xarelto |
| Amgen INC. | $247.30 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.43 | 2019-2023 | Jardiance |
| Novo Nordisk INC | $120.88 | 2019-2020 | |
| Pfizer INC. | $116.71 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.70 | 2019-2023 | Lifevest |
| Amarin Pharma, INC. | $96.15 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $96.06 | 2019-2023 | Eliquis |
| Sanofi-Aventis U.S. LLC | $92.19 | 2019 | |
| Merck Sharp & Dohme LLC | $90.16 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $58.82 | 2020-2022 | |
| Actelion Pharmaceuticals US, INC. | $56.32 | 2019-2022 | |
| Tactile Systems Technology INC | $46.58 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Abbott Laboratories | $43.22 | 2021-2025 | Gallant |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $42.15 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $37.48 | 2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $36.94 | 2024 | Assure Wcd |
| Boston Scientific Corporation | $32.62 | 2019-2022 | |
| Scpharmaceuticals INC. | $20.82 | 2023 | |
| Medtronic Vascular, INC. | $16.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surender Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.